TABLE 1.
Peptide | Amino acid sequence | Mean IC50 (nM) ± SD |
---|---|---|
PB11-15 | MDVNPTLLFLKVPAQ | 41.3 ± 11.1 |
PB11-11 | MDVNPTLLFLK---- | 1,611.3 ± 281.0 |
PB15-11 | ----PTLLFLK---- | >10,000* |
PB15-11T6Y | ----PYLLFLK---- | >10,000* |
PB15-11T6W | ----PWLLFLK---- | >10,000* |
Determination of the 50% inhibitory concentrations (IC50s) of PB11-15-derived peptides by competitive ELISA using cell extract containing HA-tagged PA of A/WSN/33 and increasing concentrations of competitive peptides. Asterisks indicate the highest concentrations of competitive peptides (10,000 nM) used without detectable inhibitory effect. Affinity-enhancing amino acids are highlighted in boldface.